LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Home・Listă Acțiuni・Pfizer

Pfizer

Deschisă

Sector Sănătate

30.09 2.84

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

29.26

Maxim

30.12

Indicatori cheie
By Trading Economics
Venit	-3.1B 41M
Vânzări	-1.6B 13B
P/E Medie Sector	15.73 103.001
EPS	0.6
Marjă de profit	0.308
Angajați	88,000
EBITDA	-3.5B 2.4B

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+11.96 upside

Dividende
By Dow Jones
Următoarele câștiguri	29 oct. 2024
Data viitoare de dividende	2 dec. 2024
Următoarea dată ex-dividende	7 nov. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	164B
Deschiderea anterioară	27.25
Închiderea anterioară	30.09

Sentimentul știrilor

By Acuity

68%

32%

311 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

29.19 / 29.74 Suport & Rezistență

Pfizer Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 sept. 2024, 10:28 UTC

Câștiguri

Pfizer, Valneva Report Positive Lyme Disease Vaccine Candidate Data

12 sept. 2024, 17:01 UTC

Top știri

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- Update

12 sept. 2024, 11:00 UTC

Top știri

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- WSJ

12 sept. 2024, 10:00 UTC

Top știri

Moderna Pulls Back on R&D and Delays Timeline for Profitability -- Barrons.com

6 sept. 2024, 11:00 UTC

Top știri

Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ

3 sept. 2024, 17:22 UTC

Top știri

Pfizer Better Watch Out for This Biotech -- Heard on the Street-- WSJ

3 sept. 2024, 10:31 UTC

Market Talk

Valneva Shares Gain on Positive Vaccine News -- Market Talk

23 aug. 2024, 18:38 UTC

Top știri

The U.S. Is Bringing Back Free Covid Tests This Fall -- Barrons.com

19 aug. 2024, 09:30 UTC

Top știri

Achiziții, Fuziuni, Preluări

Pfizer Is Staking Its Turnaround on Cancer Drugs -- WSJ

8 aug. 2024, 10:30 UTC

Top știri

Big Pharma Cuts R&D, Sending Shudders Through Industry -- Heard on the Street -- WSJ

1 aug. 2024, 15:56 UTC

Câștiguri

Merck Created the World's Biggest Drug. Now It -2-

1 aug. 2024, 15:56 UTC

Câștiguri

Merck Created the World's Biggest Drug. Now It Has to Replace It. -- Barrons.com

1 aug. 2024, 10:30 UTC

Top știri

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

30 iul. 2024, 17:18 UTC

Câștiguri

Pfizer Raises Outlook Amid Strong Demand for Non-Covid Products -- WSJ

30 iul. 2024, 15:53 UTC

Câștiguri

Nasdaq Dives As Microsoft Earnings Loom; Two Dow Jones Leaders Crater On Earnings (Live Updates) -- IBD

30 iul. 2024, 15:52 UTC

Top știri

Heard on the Street: Pfizer Finally Gets Past Covid -- WSJ

30 iul. 2024, 11:37 UTC

Câștiguri

Pfizer Stock Rises After Guidance Hike, Earnings Beat. -- Barrons.com

30 iul. 2024, 11:18 UTC

Top știri

Câștiguri

Pfizer Stock Rises After Drug Maker Raises Outlook -- WSJ

30 iul. 2024, 11:12 UTC

Câștiguri

Pfizer Stock Rises On Earnings Beat, Raised Outlook -- IBD

30 iul. 2024, 11:01 UTC

Câștiguri

Pfizer's Stock Pops After Earnings Beat As Company Raises Guidance And Unveils Cost Cuts -- MarketWatch

30 iul. 2024, 10:50 UTC

Câștiguri

Pfizer: Current Guidance Doesn't Anticipate Any Share Repurchases in 2024 >PFE

30 iul. 2024, 10:49 UTC

Câștiguri

Pfizer Sees 2024 Adjusted R&D Expenses $11B-$12B >PFE

30 iul. 2024, 10:49 UTC

Câștiguri

Pfizer Had Seen 2024 Adjusted EPS $2.15-$2.35 >PFE

30 iul. 2024, 10:48 UTC

Câștiguri

Pfizer Now Sees 2024 Operational Rev Growth of 9%-11%; Had Seen 8%-10% >PFE

30 iul. 2024, 10:47 UTC

Câștiguri

Pfizer Raises 2024 View To Adj EPS $2.45-Adj EPS $2.65 >PFE

30 iul. 2024, 10:47 UTC

Câștiguri

Pfizer Raises 2024 View To Rev $59.5B-$62.5B >PFE

30 iul. 2024, 10:47 UTC

Câștiguri

Pfizer 2Q Biopharma Revenue $12.99B, Up 2% >PFE

30 iul. 2024, 10:46 UTC

Câștiguri

Pfizer: On Track for at Least $4B Net Cost Savings by End 2024 From Cost-Realignment Program >PFE

30 iul. 2024, 10:45 UTC

Câștiguri

Pfizer Posts $1.3B 2Q Costs for Manufacturing Optimization Program >PFE

30 iul. 2024, 10:45 UTC

Câștiguri

Pfizer Raises 2024 Guidance >PFE

Comparație

Modificare preț

Pfizer Așteptări

Obiectiv de preț

By TipRanks

11.96% sus

Prognoză pe 12 luni

Medie 32.77 USD 11.96%

Maxim 45 USD

Minim 27 USD

În baza a 18 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPfizer - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

18 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 18 analiști care au acordat evaluări ale acțiunilor Pfizer - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

29.19 / 29.74Suport & Rezistență

Bullish events outweigh bearish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

311 / 365 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Pfizer

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.